SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global home infusion therapy market is estimated to be valued at US$ 1,995.3 million in 2020 and is expected to exhibit a CAGR of 6 ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen (AB), a global healthcare company, today announces a program designed to help hospitals and health systems launch or optimize home infusion ...

Option Care Health gives investors exposure to two healthcare megatrends: (i) the shift to healthcare delivery in the home; and (ii) the development of specialty pharmaceuticals. I believe OPCH holds ...

SOMERSET, Wis. (WCCO) — Home infusion is meant to help patients become independent and resume normal activities while recovering from an illness. The COVID-19 pandemic jump-started the growth of the ...

Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to offer ...

Editor's note: This article was updated to add comments from the National Home Infusion Association. Between 2008 and 2019, the use of home infusion therapy grew by 300%, according to the National ...

Option Care Health, the largest alternative infusion provider, is poised to benefit from the shift to home-based health and the growing specialty pharmaceuticals market. Despite the 13% drop YTD, OPCH ...

At WHX 2026 Dubai, Alexei Cernenco, OSAA Innovation Board Member and QA/RA Manager, outlines how domiciliary IV therapy is evolving from a niche offering into a strategic component of regional ...